Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence.
3 contributing indexes 4 score components composite score.
Canonical asset packet first: fundamentals, macro index exposure, entry value, and active narrative alignment. Driver rows link back to the public index that moved the score.
| Index | Driver | Reason | Weight | Condition | Contribution | As Of |
|---|---|---|---|---|---|---|
| RQRI | Risk-Quality Rotation Index | risk appetite | 9% | risk appetite — tailwind Moderate signal—/100Tailwind +1.30σ | +0.085 | 2026-05-22 |
| LFSI | Liquidity & Financial Stress Index | liquidity conditions | 23% | liquidity conditions — tailwind Near normal—/100Tailwind +0.13σ | +0.042 | 2026-05-22 |
| CRSI | Credit Spread Intensity Index | credit spreads | 10% | credit spreads — headwind Near normal—/100Headwind -0.27σ | -0.036 | 2026-05-22 |
